Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $164 at BofA Securities

October 12, 2026 6:17 AM
BofA Securities analyst Tazeen Ahmad raised the price target on Gilead Sciences (NASDAQ: GILD) to $164.00 (from $162.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change